The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma

International Journal of Oncology

Volumn 46, Issue 6, 2015, Pages 2364-2370

  Yoshikawa, Kyohei ^a   Noguchi, Kazuma ^a   Nakano, Yoshiro ^a   Yamamura, Michiyo ^a   Takaoka, Kazuki ^a   Hashimoto Tamaoki, Tomoko ^a   Kishimoto, Hiromitsu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Acquired resistance; Cisplatin; Hippo pathway; Oral squamous cell carcinoma; Yes associated protein

Indexed keywords

CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GLUTATHIONE TRANSFERASE P1; PROTEIN KINASE YES; SMALL INTERFERING RNA; WILSON DISEASE PROTEIN; ANTINEOPLASTIC AGENT; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER PATIENT; CANCER RESISTANCE; CELLULAR DISTRIBUTION; CORRELATIONAL STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INVESTIGATIVE PROCEDURES; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CELL NUCLEUS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; METABOLISM; MOUTH TUMOR; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL NUCLEUS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; PHOSPHOPROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84928538463     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2948     Document Type: Article

References (37)

1. Haddad RI and Shin DM: Recent advances in head and neck cancer. N Engl J Med 359: 1143-1154, 2008.
2. Overgaard J, Mohanti BK, Begum N, Ali R, Agarwal JP, Kuddu M, Bhasker S, Tatsuzaki H and Grau C: Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): A randomised, multicentre trial. Lancet Oncol 11: 553-560, 2010.
3. Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, Tilanus MG, Koole R, Hordijk GJ, van der Vliet PC, et al: An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37: 182-186, 2005.
4. Weaver A, Fleming S, Ensley J, Kish JA, Jacobs J, Kinzie J, Crissman J and Al-Sarraf M: Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer. Am J Surg 148: 525-529, 1984.
5. Rooney M, Kish J, Jacobs J, Kinzie J, Weaver A, Crissman J and Al-Sarraf M: Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55: 1123-1128, 1985.
6. Wang D and Lippard SJ: Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4: 307-320, 2005.
7. Hall MD, Okabe M, Shen DW, Liang XJ and Gottesman MM: The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol 48: 495-535, 2008.
8. Shen DW, Pouliot LM, Hall MD and Gottesman MM: Cisplatin resistance: A cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev 64: 706-721, 2012.
9. Avruch J, Zhou D, Fitamant J and Bardeesy N: Mst1/2 signalling to Yap: Gatekeeper for liver size and tumour development. Br J Cancer 104: 24-32, 2011.
10. Wang K, Degerny C, Xu M and Yang XJ: YAP, TAZ, and Yorkie: A conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol 87: 77-91, 2009.
11. Yuan M, Tomlinson V, Lara R, Holliday D, Chelala C, Harada T, Gangeswaran R, Manson-Bishop C, Smith P, Danovi SA, et al: Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 15: 1752-1759, 2008.
12. Vidal M and Cagan RL: Drosophila models for cancer research. Curr Opin Genet Dev 16: 10-16, 2006.
13. Nylander K, Coates PJ and Hall PA: Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 87: 368-372, 2000.
14. Lo Muzio L, Santarelli A, Caltabiano R, Rubini C, Pieramici T, Trevisiol L, Carinci F, Leonardi R, De Lillo A, Lanzafame S, et al: p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 36: 187-194, 2005.
15. Ge L, Smail M, Meng W, Shyr Y, Ye F, Fan KH, Li X, Zhou HM and Bhowmick NA: Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis. PLoS One 6: e27529, 2011.
16. Zhao Y, Khanal P, Savage P, She YM, Cyr TD and Yang X: YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway. Cancer Res 74: 4493-4503, 2014.
17. Yamamura M, Noguchi K, Nakano Y, Segawa E, Zushi Y, Takaoka K, Kishimoto H, Hashimoto-Tamaoki T and Urade M: Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells. Int J Oncol 42: 873-880, 2013.
18. Köberle B, Tomicic MT, Usanova S and Kaina B: Cisplatin resistance: Preclinical findings and clinical implications. Biochim Biophys Acta 1806: 172-182, 2010.
19. Liu AM, Wong KF, Jiang X, Qiao Y and Luk JM: Regulators of mammalian Hippo pathway in cancer. Biochim Biophys Acta 1826: 357-364, 2012.
20. Solioz M and Vulpe C: CPx-type ATPases: A class of P-type ATPases that pump heavy metals. Trends Biochem Sci 21: 237-241, 1996.
21. Culotta VC, Lin SJ, Schmidt P, Klomp LW, Casareno RL and Gitlin J: Intracellular pathways of copper trafficking in yeast and humans. Adv Exp Med Biol 448: 247-254, 1999.
22. Katano K, Safaei R, Samimi G, Holzer A, Rochdi M and Howell SB: The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol Pharmacol 64: 466-473, 2003.
23. Samimi G, Katano K, Holzer AK, Safaei R and Howell SB: Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Mol Pharmacol 66: 25-32, 2004.
24. Safaei R and Howell SB: Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol 53: 13-23, 2005.
25. Yoshizawa K, Nozaki S, Kitahara H, Ohara T, Kato K, Kawashiri S and Yamamoto E: Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Oncol Rep 18: 987-991, 2007.
26. Hong W and Guan KL: The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol 23: 785-793, 2012.
27. Sudol M and Harvey KF: Modularity in the Hippo signaling pathway. Trends Biochem Sci 35: 627-633, 2010.
28. Yu FX and Guan KL: The Hippo pathway: Regulators and regulations. Genes Dev 27: 355-371, 2013.
29. Guo X and Zhao B: Integration of mechanical and chemical signals by YAP and TAZ transcription coactivators. Cell Biosci 3: 33, 2013.
30. Lai D, Visser-Grieve S and Yang X: Tumour suppressor genes in chemotherapeutic drug response. Biosci Rep 32: 361-374, 2012.
31. Carey TE, Van Dyke DL and Worsham MJ: Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res 13 (6B): 2561-2567, 1993.
32. Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC and Albertson DG: Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24: 4232-4242, 2005.
33. Lai D, Ho KC, Hao Y and Yang X: Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res 71: 2728-2738, 2011.
34. Visser S and Yang X: Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray. Gene 449: 22-29, 2010.
35. Kawahara M, Hori T, Chonabayashi K, Oka T, Sudol M and Uchiyama T: Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73. Blood 112: 3856-3866, 2008.
36. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, et al: The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147: 759-772, 2011.
37. Frisch SM, Schaller M and Cieply B: Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. J Cell Sci 126: 21-29, 2013.